Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors | Naviance

La combinación de fármacos experimentales es prometedora contra tumores difíciles de tratar

Experimental Drug Combination Shows Promise Against Hard-to-Treat Tumors

La combinación de un par de medicamentos experimentales puede ayudar a tratar tumores malignos de la vaina del nervio periférico con menos efectos secundarios dañinos, según estudios preliminares en animales dirigidos por investigadores del Centro Oncológico Johns Hopkins Kimmel y Descubrimiento de fármacos de Johns Hopkins.

LEER AQUÍ

VER TODAS LAS NOTICIAS

Mensajes recientes

New Technology: MRI-guided Focused Ultrasound for Prostate Cancer Advances in Breast Cancer Treatment: Insights from Medical Oncologist Jenni Sheng Early Immunotherapy Shows Promising Results in Advanced Basal Cell Carcinoma New NIH-Funded Johns Hopkins Medicine Study Finds High-Risk Individuals Who Have Mild Dilatation of the Pancreatic Duct Have Increased Risk for Pancreatic Cancer Lung Cancer Symptoms Doctors Say Women Should Never Ignore and the Screening Most Skip Targeted Radiation During Surgery Reduces Pancreatic Cancer Recurrence Colorectal Cancer Is Becoming More Common In Young People. Here Are The Signs. Johns Hopkins-Led Study Finds Drugs Approved for Treating Pain Also Reduce Bone Cancer Growth DNA Shed by Colon Cancers May Help Oncologists Personalize Postsurgical Treatment